Skip to main content
CAMP logo
CAMP
(NASDAQ)
Camp4 Therapeutics Corporation
$4.47-- (--)
Loading... - Market loading

Camp4 Therapeutics (CAMP) Stock Price & Financial Analysis

Camp4 Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.36 - $4.58
52-Week High$7.75
52-Week Low$1.31
Open$4.39
Volume37.88K
Average Volume (3M)37.88K
Market Cap232.00M
Shares Outstanding51.90M
Price to Sales (P/S)66.18
Price to Book (P/B)4.85
EV/EBITDA-2.46
Revenue (TTM)3.50M
Net Income (TTM)-80.40M
Free Cash Flow (TTM)-30.07M
EPS (TTM)$-1.55
Profit Margin-2298.54%
Operating Margin-1488.31%
Return on Equity (ROE)-168.55%
Debt to Equity0.04
50-Day MA$4.48
200-Day MA$3.50
52-Week Change15.54%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Camp4 Therapeutics

What is the current stock price for CAMP?

As of the latest trading session, CAMP stock trades at $4.47. The 52-week range is $1.31–$7.75, with a day range of $4.36–$4.58.

What is the P/E ratio for CAMP?

The P/E ratio (Price-to-Earnings) for CAMP is shown in the Key Statistics section. This valuation metric helps compare Camp4 Therapeutics Corporation to industry peers.

Does CAMP pay dividends?

Camp4 Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CAMP?

Based on 1 analyst, the consensus for CAMP is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CAMP?

Camp4 Therapeutics's market capitalization is $232.0M, classifying it as a micro-cap company. Camp4 Therapeutics operates in the Healthcare sector within the Biotechnology industry.